203 related articles for article (PubMed ID: 35164157)
1. Evaluation of Anticancer and Antibacterial Activity of Four 4-Thiazolidinone-Based Derivatives.
Skóra B; Lewińska A; Kryshchyshyn-Dylevych A; Kaminskyy D; Lesyk R; Szychowski KA
Molecules; 2022 Jan; 27(3):. PubMed ID: 35164157
[TBL] [Abstract][Full Text] [Related]
2. 4-thiazolidinone-based derivatives rosiglitazone and pioglitazone affect the expression of antioxidant enzymes in different human cell lines.
Szychowski KA; Skóra B; Kryshchyshyn-Dylevych A; Kaminskyy D; Khyluk D; Lesyk R
Biomed Pharmacother; 2021 Jul; 139():111684. PubMed ID: 34243632
[TBL] [Abstract][Full Text] [Related]
3. Anticancer properties of 4-thiazolidinone derivatives depend on peroxisome proliferator-activated receptor gamma (PPARγ).
Szychowski KA; Leja ML; Kaminskyy DV; Kryshchyshyn AP; Binduga UE; Pinyazhko OR; Lesyk RB; Tobiasz J; Gmiński J
Eur J Med Chem; 2017 Dec; 141():162-168. PubMed ID: 29031063
[TBL] [Abstract][Full Text] [Related]
4. New 4-thiazolidinone-based molecules Les-2769 and Les-3266 as possible PPARγ modulators.
Bar M; Skóra B; Tabęcka-Łonczyńska A; Holota S; Khyluk D; Roman O; Lesyk R; Szychowski KA
Bioorg Chem; 2022 Nov; 128():106075. PubMed ID: 35952447
[TBL] [Abstract][Full Text] [Related]
5. Anticancer properties of 5Z-(4-fluorobenzylidene)-2-(4-hydroxyphenylamino)-thiazol-4-one.
Szychowski KA; Kaminskyy DV; Leja ML; Kryshchyshyn AP; Lesyk RB; Tobiasz J; Wnuk M; Pomianek T; Gmiński J
Sci Rep; 2019 Jul; 9(1):10609. PubMed ID: 31337851
[TBL] [Abstract][Full Text] [Related]
6. 4-Thiazolidinone derivative Les-3833 effectively inhibits viability of human melanoma cells through activating apoptotic mechanisms.
Finiuk N; Boiko N; Klyuchivska O; Коbylinska L; Kril I; Zimenkovsky B; Lesyk R; Stoika R
Croat Med J; 2017 Apr; 58(2):129-139. PubMed ID: 28409496
[TBL] [Abstract][Full Text] [Related]
7. Study of antineoplastic action of novel isomeric derivatives of 4-thiazolidinone.
Chumak VV; Fil MR; Panchuk RR; Zimenkovsky BS; Havrylyuk DY; Lesyk RB; Stoika RS
Ukr Biochem J; 2014; 86(6):96-105. PubMed ID: 25816610
[TBL] [Abstract][Full Text] [Related]
8. Pyrrolidinedione-thiazolidinone hybrid molecules with potent cytotoxic effect in squamous cell carcinoma SCC-15 cells.
Finiuk N; Kaleniuk E; Holota S; Stoika R; Lesyk R; Szychowski KA
Bioorg Med Chem; 2023 Sep; 92():117442. PubMed ID: 37579525
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, Characterization, Molecular Docking, In Vitro Biological Evaluation and In Vitro Cytotoxicity Study of Novel Thiazolidine-4-One Derivatives as Anti-Breast Cancer Agents.
Kadhim ZY; Alqaraghuli HGJ; Abd MT
Anticancer Agents Med Chem; 2021; 21(17):2397-2406. PubMed ID: 33797379
[TBL] [Abstract][Full Text] [Related]
10. Differential pro-apoptotic effects of synthetic 4-thiazolidinone derivative Les-3288, doxorubicin and temozolomide in human glioma U251 cells.
Коbylinska LI; Klyuchivska OY; Grytsyna II; Finiuk N; Panchuk RR; Starykovych MO; Lehka L; Lesyk RB; Zіmenkovsky BS; Stoika RS
Croat Med J; 2017 Apr; 58(2):150-159. PubMed ID: 28409498
[TBL] [Abstract][Full Text] [Related]
11. Novel ciprofloxacin hybrids using biology oriented drug synthesis (BIODS) approach: Anticancer activity, effects on cell cycle profile, caspase-3 mediated apoptosis, topoisomerase II inhibition, and antibacterial activity.
Kassab AE; Gedawy EM
Eur J Med Chem; 2018 Apr; 150():403-418. PubMed ID: 29547830
[TBL] [Abstract][Full Text] [Related]
12. 4-Thiazolidinone-based derivatives do not affect differentiation of mouse embryo fibroblasts (3T3-L1 cell line) into adipocytes.
Szychowski KA; Skóra B; Kryshchyshyn-Dylevych A; Kaminskyy D; Tobiasz J; Lesyk RB; Gmiński J
Chem Biol Interact; 2021 Aug; 345():109538. PubMed ID: 34097888
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological evaluation of new 4-thiazolidinone derivatives.
Güzel O; Salman A
J Enzyme Inhib Med Chem; 2009 Aug; 24(4):1015-23. PubMed ID: 19624255
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis, and biological evaluation of imidazopyridine-linked thiazolidinone as potential anticancer agents.
Iqbal MA; Husain A; Alam O; Khan SA; Ahmad A; Haider MR; Alam MA
Arch Pharm (Weinheim); 2020 Oct; 353(10):e2000071. PubMed ID: 32627909
[TBL] [Abstract][Full Text] [Related]
15. Optimization of 2-(3-(arylalkyl amino carbonyl) phenyl)-3-(2-methoxyphenyl)-4-thiazolidinone derivatives as potent antitumor growth and metastasis agents.
Wu J; Yu L; Yang F; Li J; Wang P; Zhou W; Qin L; Li Y; Luo J; Yi Z; Liu M; Chen Y
Eur J Med Chem; 2014 Jun; 80():340-51. PubMed ID: 24794770
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, antimicrobial, anticancer evaluation and QSAR studies of thiazolidin-4-ones clubbed with quinazolinone.
Deep A; Narasimhan B; Ramasamy K; Mani V; Mishra RK; Majeed AB
Curr Top Med Chem; 2013 Aug; 13(16):2034-46. PubMed ID: 23895092
[TBL] [Abstract][Full Text] [Related]
17. Design, Synthesis and In vitro Biological Activity of Some New 1,3- thiazolidine-4-one Derivatives as Chemotherapeutic Agents using Virtual Screening Strategies.
Nayak P; Kachroo M
Curr Comput Aided Drug Des; 2020; 16(6):757-771. PubMed ID: 31951175
[TBL] [Abstract][Full Text] [Related]
18. Novel Mannich bases of ciprofloxacin with improved physicochemical properties, antibacterial, anticancer activities and caspase-3 mediated apoptosis.
Abdel-Rahman IM; Mustafa M; Mohamed SA; Yahia R; Abdel-Aziz M; Abuo-Rahma GEA; Hayallah AM
Bioorg Chem; 2021 Feb; 107():104629. PubMed ID: 33482607
[TBL] [Abstract][Full Text] [Related]
19. Toxicity and structure-activity relationship (SAR) of α,β-dehydroamino acids against human cancer cell lines.
Videira RA; Andrade PB; Monteiro LS; Valentão P; Ferreira PMT; Pereira DM
Toxicol In Vitro; 2018 Mar; 47():26-37. PubMed ID: 29107685
[TBL] [Abstract][Full Text] [Related]
20. Cytotoxic and Apoptotic Effects of Novel Pyrrolo[2,3-d]Pyrimidine Derivatives Containing Urea Moieties on Cancer Cell Lines.
Kilic-Kurt Z; Bakar-Ates F; Karakas B; Kütük Ö
Anticancer Agents Med Chem; 2018; 18(9):1303-1312. PubMed ID: 29866023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
